Our laboratory has previously demonstrated that
15-lipoxygenase (15-LO)/15-hydroxyeicosatetr-aenoic
acid (15-HETE) is involved in hypoxic
pulmonary arterial hypertension (PAH). Phenotypical alterations of vascular smooth muscle cells are considered to be an important stage in the development of PAH, whereas the underlying mechanisms and signaling systems are still unclear. Here, we determined the contribution of 15-LO/15-
HETE signaling in the
hypoxia-induced phenotype changes of pulmonary arterial smooth muscle cells (PASMCs). To accomplish this, cellular and molecular changes in pulmonary
vascular remodeling were detected in PAH patients and rats exposed to
hypoxia. We found that the
hypoxia-induced alterations in PASMCs phenotypes were reversed by the inhibition of 15-LO/15-
HETE or inhibition of BMP4/BMPRI.
Hypoxia-induced 15-LO1/2 expression in rat PASMCs was significantly abolished by
small interfering RNA targeted at BMP4. Meanwhile, BMP4/BMPRI-15-LO/15-
HETE had a positive feedback mechanism. Furthermore, ERK and p38MAPK act as the downstream of the 15-LO/15-
HETE-BMP4/BMPRI signaling. Our results suggest that chronic
hypoxia promotes phenotypical alterations of PASMCs due to the interaction between 15-LO/15-
HETE and BMP4/BMPRI. Our study reveals a novel mechanism of
hypoxia-induced pulmonary
vascular remodeling and suggested new therapeutic strategies for the targeting of 15-LO/15-
HETE and BMP4/BMPRI in PAH treatment.